The nasal cannula is a tool that is utilized for providing oxygen or rising the passage of oxygen to a sufferer distressing from lung illness. This tool is prepared up of trivial polythene or silicon pipes which divide into two strings which are fitted in the nose of the sufferers for oxygen flow. The others side of this conduit is linked to an oxygen producer or passage meter. This nose pipe transmits nearly1–3 L of oxygen per minute. It can vary as per necessity of the sufferers. The rising ubiquity of lung illness is anticipated to fuel the nasal cannula market. As per a survey generated on September 29, 2020, as per NCBI, 39% of corona virus sufferers distressed from ARDS, showing a huge requirement for supplying oxygen requirements for sufferers, which is anticipated to develop the nasal cannula market.
The global nasal cannula market is projected to be evaluated at US$ 6,801.7 Mn in 2021 and is anticipated to show a CAGR of 6.4 % during the predicted duration (2021-2028).
Get Free Sample PDF Copy (Including Full TOC, List of Tables & Figures, Chart) @
Impact of the Coronavirus
COVID-19 has impacted the breathing methods of sufferers, leading a low concentration of oxygen in sufferers, required to supply additional oxygen to heal from breathing problems, which is anticipated to fuel the development of the global nasal cannula market during the predicted duration. For example, an article generated on October 1, 2020, in PubMed regarding HFNC treatment for coronavirus, concludes that the usage of a HFNC for severely sick sufferers with coronavirus assists in reinstating oxygen for serious acute lung failure difficulties. This survey proposed that HFNC decreased intubation rate and death rate in severely sick sufferers owing to coronavirus and survey stated that HFNC is protective for giving quality oxygen to coronavirus sufferers distressing from lung failure.
Rising perception regarding lung illness by the key players is anticipated to show the development of the nasal cannula market during the predicted duration. For example, in June 2021, the MHFW, India allotted rules for hospitalization of coronavirus caution facilities for kids and elders, which publish that safety and rules should be surveyed for kids impacted by coronavirus. Kids must test for RTPCR and CBNAAT trials for the analysis of coronavirus. Post the positive report, kids with average prodromes can be cured indoor, but in serious situation such as breathlessness and indefinite oxygen capacity, they should be hospitalized to pandemic zones having services for oxygen treatment, ICU and HDU
Rising R&D by the key players for advancing the therapy for lung diseases is anticipated to fuel the development of the global nasal cannula market during the predicted duration.
Key players are included in R&D actions to increase therapies for lung illness. This is anticipated to rise the development of the nasal cannula market during the predicted duration. For example, In Karger which is information where technical and clinical associated articles and modern analysis in bio sciences are generated, In February 2020 survey generated regarding medical proofs of NHFT for COPD sufferers published that survey were performed on sufferers with various clinical situations, such as enduring NHFT in constant sufferers with COPD, enduring bronchiectasis, persistent hypoxemic outbreak, and enduring hypercapnic respiratory outbreak , where this survey lead as the observance of nasal high flow treatment required for COPD or bronchiectasis was 1.6 hrs. daily ,for enduring hypoxemic outbreak it was 6 hrs daily and for persistent hypercapnic 20L / min were provided for 6 weeks.
Key companies are involved in supplying needed appliances and therapy for breathing issues occurred owing to several reasons such as coronavirus, asthma, and pneumonia carcinoma, which is anticipated to fuel the development of the nasal cannula market during the predicted duration. For example, on July 17, 2020, the HM of Tamil Nadu approved US$ 10.2 million to purchase 2,414 huge-flow nostril cannulas to control sufferers with gasping owing to COVID-19.These high flow nasal cannulas are utilized to decrease pain in sufferer and aid with fast healing from infected lungs.
The rising frequency of breathing illness globally shows the requirement for developed machineries for hospital facilities to give oxygen supply to sufferers, so there are many substitute choices accessible in market, which is anticipated to hinder the development of the nasal cannula market during the predicted duration. For example, the accessibility of choices such as whole face mask, full mask with tube and venturi mask that can be utilized for providing oxygen to the sufferer can hinder the merchandise of nasal cannulas.
The rising usage of nose cannula can also lead to complications like the diffusion of pathogenic worms from nasal cannula that can lead to inflammation in sufferers, which is anticipated to hinder the development of the market during the predicted duration. For example, a news by the SBU on August 6, 2020, published the threat of viral inflammation diffusion to sufferers via vast-passage nose cannula while supplying oxygen treatment to sufferers. A sufferer can be inflammated from aerosol diffusion, which means breath of worms from the nostrils.
Regionally, the global nasal cannula market is divided into Asia Pacific, Africa North America, Europe, Middle East, and Latin America.
Amidst regions, North America is anticipated to keep a leading place in global nasal cannula market, due to the advancements of nasal cannula therapies, which is anticipated to fuel the development during the predicted duration. For example, on July 28, 2021, Vyaire Medical, a U.S based industry initiated low passage of oxygen treatment appliance known as Airlife Open Oxygen Mask. Vyaire Clinical is a one of the dominating producers of clinical appliances. The tool, Airlife open oxygen mask, is built from license projects. This tool has capability to supply 1L- 15L per minute oxygen deprived of troubling sufferer.
Moreover, Europe is also expected to spectator notable development in the global nasal cannula market, due to the rising frequency of early birth, which is anticipated to fuel the nasal cannula market during the predicted duration. For example, Medin Medical Innovations GmbH, Germany based organization which is a dominating producer of nasal cannula for earlier babies has advanced Nuflow. This Nuflow nasal cannula is built up of soft and well-suited silicone which supplies oxygen at 8Lit / min to kids distressing from cardiac and pneumonic difficulties.
Request PDF Brochure with Latest Insights @
Key companies set up in the global nasal cannula market are Teleflex Incorporated,Medtronic plc., Maquet Holding B.V. & Co. KG , Terumo Corporation, Drive Devilbiss International, Smiths Medical, Besmed Health Business Corp.,Edward LifeSciences Corp., Flexicare Medical, Vapotherm Inc., Medin Medical innovations, Sorin Group, Salter Labs, Well Lead Medical Co. Ltd., Allied Healthcare Products, and Fairmont Medical.
Reasons to buy this Nasal Cannula Market Report
◘ Save time carrying out entry-level research by identifying the size, growth, and leading players in the emerging Nasal Cannula Market
◘ Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the emerging Nasal Cannula Market
◘ Leading company profiles reveal details of key Nasal Cannula Market players emerging five operations and financial performance
◘ Add weight to presentations and pitches by understanding the future growth prospects of the emerging Nasal Cannula Market with five year historical forecasts
◘ Compares data from North America, South America, Asia Pacific Europe and Middle East Africa, alongside individual chapters on each region
The next part also sheds light on the gap between supply and consumption. Apart from the mentioned information, growth rate of Nasal Cannula Market in 2028 is also explained. Additionally, type wise and application wise consumption tables and figures of Nasal Cannula Market are also given.
𝐁𝐮𝐲 𝐓𝐡𝐢𝐬 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐁𝐮𝐬𝐢𝐧𝐞𝐬𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐖𝐢𝐭𝐡 𝐅𝐥𝐚𝐭 𝐔𝐒𝐃 𝟐𝟎𝟎𝟎 𝐎𝐟𝐟 @
Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Nasal Cannula Market Size Analysis from 2022 to 2028
11.6 COVID-19 Outbreak: Nasal Cannula Industry Impact
Chapter 2 Global Nasal Cannula Competition by Types, Applications, and Top Regions and Countries
2.1 Global Nasal Cannula (Volume and Value) by Type
2.3 Global Nasal Cannula (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Nasal Cannula Sales, Consumption, Export, Import by Regions
Chapter 5 North America Nasal Cannula Market Analysis
Chapter 6 East Asia Nasal Cannula Market Analysis
Chapter 7 Europe Nasal Cannula Market Analysis
Chapter 8 South Asia Nasal Cannula Market Analysis
Chapter 9 Southeast Asia Nasal Cannula Market Analysis
Chapter 10 Middle East Nasal Cannula Market Analysis
Chapter 11 Africa Nasal Cannula Market Analysis
Chapter 12 Oceania Nasal Cannula Market Analysis
Chapter 13 South America Nasal Cannula Market Analysis
Chapter 14 Company Profiles and Key Figures in Nasal Cannula Business
Chapter 15 Global Nasal Cannula Market Forecast (2022-2028)
Chapter 16 Conclusions
About Coherent Market Insights
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027